Peripheral immune tolerance is the collection of mechanisms that prevent mature lymphocytes from mounting harmful responses to the body’s own tissues and certain harmless foreign substances. It operates outside the principal sites of lymphocyte development and complements central selection mechanisms. A component of immune tolerance, it includes functional silencing, elimination of reactive cells, and suppression by specialized regulatory cells. These processes allow the immune system to retain a diverse repertoire of antigen-recognition receptors while limiting autoimmunity. Peripheral tolerance is not simply generalized immune inactivity: its mechanisms regulate particular cells and responses within specific biological contexts. (pmc.ncbi.nlm.nih.gov)
Relationship to central tolerance
Adaptive immunity depends on T cells and B cells bearing diverse receptors. Some receptors inevitably recognize self antigens. Central tolerance acts during development, principally in the thymus for T cells and bone marrow for B cells, eliminating or redirecting many self-reactive cells before they enter circulation. Nevertheless, this selection is incomplete, and potentially autoreactive lymphocytes remain in healthy individuals. Peripheral mechanisms restrain those cells after they leave their developmental organs. (pmc.ncbi.nlm.nih.gov)
The distinction is anatomical and developmental, rather than an absolute separation of cell populations. Some regulatory T cells develop in the thymus but subsequently enforce tolerance in peripheral tissues. Other regulatory T cells arise from conventional T cells outside the thymus. Together, central selection and peripheral regulation maintain immune homeostasis. (pmc.ncbi.nlm.nih.gov)
Functional silencing and deletion
Anergy is a state in which a living lymphocyte becomes poorly responsive to stimulation. For T cells, antigen recognition without adequate costimulation can induce this state. Recognition therefore does not necessarily produce proliferation or inflammatory activity: the accompanying signals help determine the outcome. Anergic cells have altered signaling and transcriptional programs, and some forms of anergy can be reversed under appropriate experimental conditions. (pmc.ncbi.nlm.nih.gov)
Clonal deletion instead removes reactive lymphocytes through apoptosis, or programmed cell death. Peripheral deletion can follow encounters with self-antigens, including antigens presented by lymph-node stromal cells. Repeated stimulation can also engage death pathways involving Fas. Anergy and deletion may overlap during the establishment of tolerance, but they differ fundamentally: one changes a cell’s responsiveness, whereas the other eliminates it. (pmc.ncbi.nlm.nih.gov)
These states should not be treated as interchangeable with T-cell exhaustion, a differentiation program associated especially with persistent antigen exposure during chronic infection or cancer. Tolerance and exhaustion can share inhibitory receptors and reduced effector function, but their initiating conditions and molecular programs differ. (pmc.ncbi.nlm.nih.gov)
Regulatory cells and inhibitory pathways
Regulatory T cells actively restrain other immune cells rather than merely remaining unresponsive themselves. The best-characterized population expresses FOXP3, a transcription factor central to its development and function. These cells can influence conventional T cells, B cells, and antigen-presenting cells through several complementary mechanisms. No single suppressive mechanism accounts for all regulatory T-cell activity across tissues. (pmc.ncbi.nlm.nih.gov)
One mechanism involves immune checkpoints, particularly CTLA-4. Regulatory T-cell CTLA-4 can reduce the availability of CD80 and CD86 costimulatory molecules on dendritic cells, limiting their capacity to activate other T cells. Regulatory cells also use inhibitory cytokines, including IL-10 and transforming growth factor beta, to restrain inflammatory responses. Their high-affinity IL-2 receptors enable consumption of this growth factor, which can limit its availability to responding cells. The relative contribution of these mechanisms depends on the target cell and tissue environment. (pmc.ncbi.nlm.nih.gov)
Peripheral B-cell tolerance
B-cell tolerance continues after cells leave the bone marrow. Self-reactive peripheral B cells may remain anergic, encounter restrictions on survival, or fail to receive the signals needed for productive activation. These checkpoints reduce the likelihood that self-recognition will lead to secretion of pathogenic antibodies. Peripheral B-cell regulation is therefore not simply a duplicate of developmental selection. (pmc.ncbi.nlm.nih.gov)
B-cell anergy involves both cell-intrinsic changes and influences from other cells. The availability of T-cell help is particularly important: recognition of an antigen by a B cell does not by itself ensure a complete antibody response. Self-reactivity also varies in degree, so peripheral regulation must accommodate a spectrum of receptor properties rather than divide all B cells into uniformly harmless or harmful categories. (pmc.ncbi.nlm.nih.gov)
Tolerance at environmental interfaces
Peripheral tolerance also regulates responses to non-self substances that normally do not require inflammatory attack. Oral tolerance is the suppression of antigen-specific responses following exposure through the gastrointestinal tract. It helps prevent inappropriate reactions to dietary proteins and is distinct from an inability to recognize them. (pmc.ncbi.nlm.nih.gov)
Intestinal antigen-presenting cells transport dietary antigens to draining lymph nodes, where they can promote antigen-specific regulatory T cells. These cells subsequently populate intestinal tissues and contribute to local and systemic suppression. This process involves coordination between antigen exposure, regulatory cells, and the intestinal environment. Disruption of tolerance to dietary antigens is relevant to food allergy and intestinal inflammation. (pubmed.ncbi.nlm.nih.gov)
Disease relevance and research
Loss of peripheral regulation can permit autoreactive lymphocytes to damage tissues. Conversely, regulatory mechanisms can limit immune responses against cancers, illustrating that pathways protecting normal tissues may also restrain desirable antitumor activity. Research in organ transplantation examines how responses to donor antigens can be controlled through deletion, hyporesponsiveness, and regulatory-cell activity. (pmc.ncbi.nlm.nih.gov)
Experimental studies distinguish these outcomes using cell survival, antigen-specific proliferation, cytokine production, and suppressive function. In oral-tolerance research, reduced antibody responses or reduced T-cell responses after antigen challenge provide functional evidence of tolerance. Results from cell cultures, animal models, and human studies require separate interpretation because the mechanisms and measured endpoints are not necessarily equivalent. (pmc.ncbi.nlm.nih.gov)